These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38002282)

  • 1. Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis.
    Nie H; Chang S; Li Y; Li F
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report.
    Huang L; Qian G; Zhang H; Li Q; Chen L; Tang X; Zhao H
    Lupus; 2024 Feb; 33(2):172-175. PubMed ID: 38081170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
    Steiger S; Ehreiser L; Anders J; Anders HJ
    Front Immunol; 2022; 13():999704. PubMed ID: 36211360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report.
    Chen JW; Zhan JY; Liang SP; Wang XD; Lin CS; Xu Q
    Int J Rheum Dis; 2023 Jul; 26(7):1417-1421. PubMed ID: 37218552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the treatment of systemic lupus erythematosus with belimumab in children.
    Deng WP
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1069-1074. PubMed ID: 34719425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
    Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
    J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT.
    Sada K; Kurita N; Noma H; Matsuki T; Quasny H; Levy RA; Jones-Leone AR; Gairy K; Yajima N
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 37017254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
    Yu X; Chen N; Xue J; Mok CC; Bae SC; Peng X; Chen W; Ren H; Li X; Noppakun K; Gilbride JA; Green Y; Ji B; Liu C; Madan A; Okily M; Tang CH; Roth DA
    Am J Kidney Dis; 2023 Mar; 81(3):294-306.e1. PubMed ID: 36058429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
    Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
    J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Belimumab for systemic lupus erythematosus - Focus on lupus nephritis.
    Plüß M; Piantoni S; Tampe B; Kim AHJ; Korsten P
    Hum Vaccin Immunother; 2022 Nov; 18(5):2072143. PubMed ID: 35588699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belimumab for the treatment of pediatric patients with lupus nephritis.
    Stohl W; Kwok A
    Expert Opin Biol Ther; 2023 Mar; 23(3):243-251. PubMed ID: 36750049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis.
    Chen S; Zhang X; Meng K; Sun Y; Shu R; Han Y; Feng Q; Li Z; Yang P; Liang J
    Front Immunol; 2023; 14():1077645. PubMed ID: 36845141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis.
    Nicolaou O; Sokratous K; Makowska Z; Morell M; De Groof A; Montigny P; Hadjisavvas A; Michailidou K; Oulas A; Spyrou GM; Demetriou C; Alarcón-Riquelme ME; Psarellis S; Kousios A; Lauwerys B; Kyriacou K
    Arthritis Res Ther; 2020 Jun; 22(1):147. PubMed ID: 32552896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.
    Dumestre-Pérard C; Clavarino G; Colliard S; Cesbron JY; Thielens NM
    Autoimmun Rev; 2018 Sep; 17(9):890-899. PubMed ID: 30009962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.